Pharma Journalist 8916 posts 0 comments

VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announce the initiation of enrollment of its…
Read More...

Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire Maverick Therapeutics, Inc. a private biopharmaceutical company pioneering conditionally active…
Read More...

Melior Pharmaceuticals (Melior) announced that it has received clearance of its Investigational New Drug (IND) application for the clinical development of its novel, first-in-class lyn…
Read More...

Eli Lilly and Company and Biolojic Design Ltd. a biotechnology company that computationally designs functional antibodies, announced a research collaboration and license agreement that…
Read More...

Exelixis, Inc. and WuXi Biologics announced the companies have entered into an exclusive license agreement to support the continued expansion of Exelixis’ oncology biologics pipeline.…
Read More...

Roche announced that the company is voluntarily withdrawing the US indication for Tecentriq (atezolizumab) in prior-platinum treated metastatic urothelial carcinoma (mUC, bladder…
Read More...

SMi Reports: SMi Group are delighted to invite you to attend the Injectable Drug Delivery which is returning on 12th - 13th May 2021 as a virtual Conference. Following on from the…
Read More...

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics, LP announced preliminary results from Ridgeback’s Phase 2a randomized, double-blind,…
Read More...

Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced it has enrolled…
Read More...

Eli Lilly and Company announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for…
Read More...